233 related articles for article (PubMed ID: 26471744)
1. Macrophages Reprogrammed In Vitro Towards the M1 Phenotype and Activated with LPS Extend Lifespan of Mice with Ehrlich Ascites Carcinoma.
Kalish SV; Lyamina SV; Usanova EA; Manukhina EB; Larionov NP; Malyshev IY
Med Sci Monit Basic Res; 2015 Oct; 21():226-34. PubMed ID: 26471744
[TBL] [Abstract][Full Text] [Related]
2. M3 Macrophages Stop Division of Tumor Cells In Vitro and Extend Survival of Mice with Ehrlich Ascites Carcinoma.
Kalish S; Lyamina S; Manukhina E; Malyshev Y; Raetskaya A; Malyshev I
Med Sci Monit Basic Res; 2017 Jan; 23():8-19. PubMed ID: 28123171
[TBL] [Abstract][Full Text] [Related]
3. C57BL/6N Mice Are More Resistant to Ehrlich Ascites Tumors Than C57BL/6J Mice: The Role of Macrophage Nitric Oxide.
Kalish S; Lyamina S; Chausova S; Kochetova L; Malyshev Y; Manukhina E; Malyshev I
Med Sci Monit Basic Res; 2015 Oct; 21():235-40. PubMed ID: 26482575
[TBL] [Abstract][Full Text] [Related]
4. [Reprogrammed M1 macrophages with inhibited STAT3, STAT6 and/or SMAD3 extends lifespan of mice with experimental carcinoma].
Kalish SV; Lyamina SV; Raetskaya AA; Malyshev II
Patol Fiziol Eksp Ter; 2017; 61(2):4-9. PubMed ID: 29215829
[TBL] [Abstract][Full Text] [Related]
5. Pyropia yezoensis glycoprotein promotes the M1 to M2 macrophage phenotypic switch via the STAT3 and STAT6 transcription factors.
Choi JW; Kwon MJ; Kim IH; Kim YM; Lee MK; Nam TJ
Int J Mol Med; 2016 Aug; 38(2):666-74. PubMed ID: 27353313
[TBL] [Abstract][Full Text] [Related]
6. Early Growth Response Gene-2 Is Essential for M1 and M2 Macrophage Activation and Plasticity by Modulation of the Transcription Factor CEBPβ.
Veremeyko T; Yung AWY; Anthony DC; Strekalova T; Ponomarev ED
Front Immunol; 2018; 9():2515. PubMed ID: 30443252
[TBL] [Abstract][Full Text] [Related]
7. Pro-inflammatory macrophage polarization enhances the anti-cancer efficacy of self-assembled galactomannan nanoparticles entrapped with hydrazinocurcumin.
Kumari M; Purohit MP; Pahuja R; Patnaik S; Shukla Y; Kumar P; Gupta KC
Drug Deliv Transl Res; 2019 Dec; 9(6):1159-1188. PubMed ID: 31440985
[TBL] [Abstract][Full Text] [Related]
8. Carbon monoxide-releasing molecule, CORM-3, modulates alveolar macrophage M1/M2 phenotype in vitro.
Yamamoto-Oka H; Mizuguchi S; Toda M; Minamiyama Y; Takemura S; Shibata T; Cepinskas G; Nishiyama N
Inflammopharmacology; 2018 Apr; 26(2):435-445. PubMed ID: 28674739
[TBL] [Abstract][Full Text] [Related]
9. [Effect of Galectin-9/Tim-3 pathway on the polarization of M1/M2 subtype in murine macrophages induced by lipopolysaccharide].
Zhang W; Zhang Y; Fang Q
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Sep; 30(9):836-841. PubMed ID: 30309408
[TBL] [Abstract][Full Text] [Related]
10. Polarization of macrophages towards M1 phenotype by a combination of 2-deoxy-d-glucose and radiation: Implications for tumor therapy.
Farooque A; Afrin F; Adhikari JS; Dwarakanath BS
Immunobiology; 2016 Feb; 221(2):269-81. PubMed ID: 26597503
[TBL] [Abstract][Full Text] [Related]
11. TLR2 stimulation impairs anti-inflammatory activity of M2-like macrophages, generating a chimeric M1/M2 phenotype.
Quero L; Hanser E; Manigold T; Tiaden AN; Kyburz D
Arthritis Res Ther; 2017 Nov; 19(1):245. PubMed ID: 29096690
[TBL] [Abstract][Full Text] [Related]
12. IL4 receptor targeting enables nab-paclitaxel to enhance reprogramming of M2-type macrophages into M1-like phenotype via ROS-HMGB1-TLR4 axis and inhibition of tumor growth and metastasis.
Vadevoo SMP; Kang Y; Gunassekaran GR; Lee SM; Park MS; Jo DG; Kim SK; Lee H; Kim WJ; Lee B
Theranostics; 2024; 14(6):2605-2621. PubMed ID: 38646639
[No Abstract] [Full Text] [Related]
13. Characterization of M1 and M2 polarization phenotypes in peritoneal macrophages after treatment with graphene oxide nanosheets.
Feito MJ; Diez-Orejas R; Cicuéndez M; Casarrubios L; Rojo JM; Portolés MT
Colloids Surf B Biointerfaces; 2019 Apr; 176():96-105. PubMed ID: 30594708
[TBL] [Abstract][Full Text] [Related]
14. Alternative reprogramming of M1/M2 phenotype of mouse peritoneal macrophages in vitro with interferon-γ and interleukin-4.
Lyamina SV; Kruglov SV; Vedenikin TY; Borodovitsyna OA; Suvorova IA; Shimshelashvili ShL; Malyshev IY
Bull Exp Biol Med; 2012 Feb; 152(4):548-51. PubMed ID: 22803130
[TBL] [Abstract][Full Text] [Related]
15. N-Propargyl Caffeamide Skews Macrophages Towards a Resolving M2-Like Phenotype Against Myocardial Ischemic Injury via Activating Nrf2/HO-1 Pathway and Inhibiting NF-ĸB Pathway.
Cheng Y; Yang C; Luo D; Li X; Le XC; Rong J
Cell Physiol Biochem; 2018; 47(6):2544-2557. PubMed ID: 29996121
[TBL] [Abstract][Full Text] [Related]
16. Novel Markers to Delineate Murine M1 and M2 Macrophages.
Jablonski KA; Amici SA; Webb LM; Ruiz-Rosado Jde D; Popovich PG; Partida-Sanchez S; Guerau-de-Arellano M
PLoS One; 2015; 10(12):e0145342. PubMed ID: 26699615
[TBL] [Abstract][Full Text] [Related]
17. Generation and characterization of murine alternatively activated macrophages.
Weisser SB; McLarren KW; Kuroda E; Sly LM
Methods Mol Biol; 2013; 946():225-39. PubMed ID: 23179835
[TBL] [Abstract][Full Text] [Related]
18. Microenvironmental effects limit efficacy of thymoquinone treatment in a mouse model of ovarian cancer.
Wilson AJ; Saskowski J; Barham W; Khabele D; Yull F
Mol Cancer; 2015 Nov; 14():192. PubMed ID: 26552746
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial Dysfunction Prevents Repolarization of Inflammatory Macrophages.
Van den Bossche J; Baardman J; Otto NA; van der Velden S; Neele AE; van den Berg SM; Luque-Martin R; Chen HJ; Boshuizen MC; Ahmed M; Hoeksema MA; de Vos AF; de Winther MP
Cell Rep; 2016 Oct; 17(3):684-696. PubMed ID: 27732846
[TBL] [Abstract][Full Text] [Related]
20. A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvement.
Trombetta AC; Soldano S; Contini P; Tomatis V; Ruaro B; Paolino S; Brizzolara R; Montagna P; Sulli A; Pizzorni C; Smith V; Cutolo M
Respir Res; 2018 Sep; 19(1):186. PubMed ID: 30249259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
